Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case–control study
- 181 Downloads
Amino acids and derivatives participate in the biosynthesis and downstream effects of numerous neurotransmitters. Variations in specific amino acids have been implicated in the pathophysiology of schizophrenia. Herein, we sought to compare levels of amino acids and derivatives between subjects with schizophrenia and healthy controls (HC). Two hundred and eight subjects with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria (DSM-IV)-defined schizophrenia and 175 age- and sex-matched HC were enrolled. The levels of twenty-five amino acids and seven related derivatives were measured in plasma samples using hydrophilic interaction liquid chromatography (HILIC) liquid chromatography–tandem mass spectrometry (LC–MS). After controlling for age, sex and body mass index (BMI), four amino acids and derivatives (i.e., cysteine, GABA, glutamine and sarcosine) were observed to be higher in the schizophrenia group when compared with HC; seven amino acids and derivatives were lower in the schizophrenia group (i.e., arginine, l-ornithine, threonine, taurine, tryptophan, methylcysteine, and kynurenine). Statistically significant differences in plasma amino-acid profiles between subjects with first-episode vs. recurrent schizophrenia for aspartate and glutamine were also demonstrated using generalized linear models controlling for age, sex, and BMI. The differences in amino acids and derivatives among individuals with schizophrenia when compared to HC may represent underlying pathophysiology, including but not limited to dysfunctional proteinogenic processes, alterations in excitatory and inhibitory neurotransmission, changes in ammonia metabolism and the urea cycle. Taken together, amino-acid profiling may provide a novel stratification approach among individuals with schizophrenia.
KeywordsAmino acid Schizophrenia Targeting profiles Liquid chromatography–mass spectrometry Metabolomics
This work was supported by Peking University Health Science Center Medical Cross Disciplinary Fund (BMU20140435). We thank Dr. Chuanbo Zhang and other medical staff from Weifang Mental Health Center for their assistance with subject recruitment, follow up and blood sample collection. Beijing Omics Bio-tech Co., Ltd for their kind help in data collection for this study.
JYW, BC, and DFW conceived and designed the study; BC, DFW, JZ, and NHH collected the data and performed the statistical analysis; BC, ZHP, EB, RSM, JYW, DFW, DC, and JDR contributed to the discussion; and JYW, ZHP, RSM, EB, MS, RBM, JDR, HZ, YQL, and QX revised the paper. All authors have read and approved the final version of this article.
This work was supported by the Medicine Interdisciplinary Seed Fund (BMU20140435) by Health Science Center, Peking University.
Compliance with ethical standards
Conflict of interests
The authors declare no conflict of interests.
This study was reviewed and approved by the Ethics Review Committee of Public Health at Peking University Health Science Center (IRB00001052-14071).
- Azizan KA, Ressom HW, Mendoza ER, Baharum SN (2017) 13C based proteinogenic amino acid (PAA) and metabolic flux ratio analysis of Lactococcus lactis reveals changes in pentose phosphate (PP) pathway in response to agitation and temperature related stresses. PeerJ 5:e3451. https://doi.org/10.7717/peerj.3451 CrossRefPubMedPubMedCentralGoogle Scholar
- Bird SS, Marur VR, Sniatynski MJ, Greenberg HK, Kristal BS (2011) Serum lipidomics profiling using LC-MS and high-energy collisional dissociation fragmentation: focus on triglyceride detection and characterization. Anal Chem 83(17):6648–6657. https://doi.org/10.1021/ac201195d CrossRefPubMedPubMedCentralGoogle Scholar
- Bonnot O, Klunemann HH, Sedel F, Tordjman S, Cohen D, Walterfang M (2014) Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review. Orphanet J Rare Dis 9:65. https://doi.org/10.1186/1750-1172-9-65 CrossRefPubMedPubMedCentralGoogle Scholar
- Cai HL, Zhu RH, Li HD, Zhang XH, Hu L, Yang W, Ye HS (2010) Elevated plasma gamma-aminobutyrate/glutamate ratio and responses to risperidone antipsychotic treatment in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 34(7):1273–1278. https://doi.org/10.1016/j.pnpbp.2010.07.006 CrossRefGoogle Scholar
- Comasco E, Vumma R, Toffoletto S, Johansson J, Flyckt L, Lewander T, Oreland L, Bjerkenstedt L, Andreou D, Soderman E, Terenius L, Agartz I, Jonsson EG, Venizelos N (2016) Genetic and functional study of L-type amino acid transporter 1 in schizophrenia. Neuropsychobiology 74(2):96–103. https://doi.org/10.1159/000455234 CrossRefPubMedGoogle Scholar
- Eyjolfsson EM, Nilsen LH, Kondziella D, Brenner E, Haberg A, Sonnewald U (2011) Altered 13C glucose metabolism in the cortico-striato-thalamo-cortical loop in the MK-801 rat model of schizophrenia. J Cereb Blood Flow Metab 31(3):976–985. https://doi.org/10.1038/jcbfm.2010.193 CrossRefPubMedGoogle Scholar
- Koido K, Innos J, Haring L, Zilmer M, Ottas A, Vasar E (2016) Taurine and epidermal growth factor belong to the signature of first-episode psychosis. Front Neurosci-Switz 10:331Google Scholar
- Koike S, Bundo M, Iwamoto K, Suga M, Kuwabara H, Ohashi Y, Shinoda K, Takano Y, Iwashiro N, Satomura Y, Nagai T, Natsubori T, Tada M, Yamasue H, Kasai K (2014) A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study. Transl Psychiatry 4:e379. https://doi.org/10.1038/tp.2014.19 CrossRefPubMedPubMedCentralGoogle Scholar
- Larovere LE, Fairbanks L, O’Neill JP, Arenas M, Marinaki A, Escuredo E, de Kremer RD (2012) Genetic defects of purine and pyrimidine metabolism in Argentina (Period 1996-2012). J Inherit Metab Dis 35:S55–S55Google Scholar
- Lee M, Jayathilake K, Dai J, Meltzer HY (2011) Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration. Psychiatry Res 185(3):328–333. https://doi.org/10.1016/j.psychres.2010.07.013 CrossRefPubMedGoogle Scholar
- Liubetskii VA, Selivestrov AV (2005) Gene expression regulation for amino acid biosynthesis and aminoacyl-tRNA synthetases in actinobacteria. Mol Biol (Mosk) 39(6):1072–1075Google Scholar
- Maeshima H, Ohnuma T, Sakai Y, Shibata N, Baba H, Ihara H, Higashi M, Ohkubo T, Nozawa E, Abe S, Ichikawa A, Nakano Y, Utsumi Y, Suzuki T, Arai H (2007) Increased plasma glutamate by antipsychotic medication and its relationship to glutaminase 1 and 2 genotypes in schizophrenia—Juntendo University Schizophrenia Projects (JUSP). Prog Neuro-Psychopharmacol Biol Psychiatry 31(7):1410–1418. https://doi.org/10.1016/j.pnpbp.2007.06.009 CrossRefGoogle Scholar
- Oresic M, Tang J, Seppanen-Laakso T, Mattila I, Saarni SE, Saarni SI, Lonnqvist J, Sysi-Aho M, Hyotylainen T, Perala J, Suvisaari J (2011) Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med 3(3):19. https://doi.org/10.1186/gm233 CrossRefPubMedPubMedCentralGoogle Scholar
- Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9(7):684–697, 643. https://doi.org/10.1038/sj.mp.4001511
- Saleem S, Shaukat F, Gul A, Arooj M, Malik A (2017) Potential role of amino acids in pathogenesis of schizophrenia. Int J Health Sci (Qassim) 11(3):63–68Google Scholar
- Sinha AK, Giblen T, AbdElgawad H, De Rop M, Asard H, Blust R, De Boeck G (2013) Regulation of amino acid metabolism as a defensive strategy in the brain of three freshwater teleosts in response to high environmental ammonia exposure. Aquat Toxicol 130–131:86–96. https://doi.org/10.1016/j.aquatox.2013.01.003 CrossRefPubMedGoogle Scholar
- Tao F, Lu P, Xu C, Zheng M, Liu W, Shen M, Ruan S (2017) Metabolomics analysis for defining serum biochemical markers in colorectal cancer patients with Qi deficiency syndrome or Yin deficiency syndrome. Evid Based Complement Altern Med 2017:7382752. https://doi.org/10.1155/2017/7382752 CrossRefGoogle Scholar
- Thakkar KN, Rosler L, Wijnen JP, Boer VO, Klomp DW, Cahn W, Kahn RS, Neggers SF (2017) 7T proton magnetic resonance spectroscopy of gamma-aminobutyric acid, glutamate, and glutamine reveals altered concentrations in patients with schizophrenia and healthy siblings. Biol Psychiatry 81(6):525–535. https://doi.org/10.1016/j.biopsych.2016.04.007 CrossRefPubMedGoogle Scholar
- Yablonsky-Alter E, Agovic MS, Gashi E, Lidsky TI, Friedman E, Banerjee SP (2009) Cocaine challenge enhances release of neuroprotective amino acid taurine in the striatum of chronic cocaine treated rats: a microdialysis study. Brain Res Bull 79(3–4):215–218. https://doi.org/10.1016/j.brainresbull.2008.12.014 CrossRefPubMedPubMedCentralGoogle Scholar
- Yao JK, Dougherty GG, Reddy RD, Keshavan MS, Montrose DM, Matson WR, Rozen S, Krishnan RR, McEvoy J, Kaddurah-Daouk R (2009) Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol Psychiatry 15(9):938–953. https://doi.org/10.1038/mp.2009.33 CrossRefPubMedPubMedCentralGoogle Scholar
- Zhong L, Cheng F, Lu X, Duan Y, Wang X (2016) Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Talanta 158:351–360. https://doi.org/10.1016/j.talanta.2016.04.049 CrossRefPubMedGoogle Scholar